reports
Barnes & Noble Education Reports Third Quarter Fiscal Year 2025 Financ...
Barnes & Noble Education Reports Third Quarter Fiscal Year 2025 Financial Results BNC First Day® Program Revenues Increased 21% YOY to $222 Million Total Revenue Growth of 2% and Gross Comparable Store Sales Growth of 7% Net Income Improves by $17 Million to $7 Million Adjusted EBITDA Improves by $6 Million to $27 Million BASKING RIDGE, N.J., March 10, 2025 (GLOBE NEWSWIRE) -- , (“Barnes & Noble Education,” “BNED,” the “Company,” “we,” “us,” “our”), a leading solutions provider for the education industry, today reported sales and earnings for the third quarter ended on January 25, 202...
Barnes & Noble Education Strengthens Leadership Team with the Appointm...
Barnes & Noble Education Strengthens Leadership Team with the Appointment of Christopher Neumann as General Counsel & Corporate Secretary and Gary Luster as Chief Accounting Officer BASKING RIDGE, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- (NYSE: BNED), a leading solutions provider for the education industry, today announced the appointment of Christopher Neumann as General Counsel & Corporate Secretary and Gary Luster as Chief Accounting Officer, effective March 3, 2025. Christopher Neumann – General Counsel & Corporate SecretaryMr. Neumann joins BNED from Six Flags — a NYSE listed publi...
Zevra Launches New Disease State Awareness Campaign, ‘Learn NPC, Read ...
Zevra Launches New Disease State Awareness Campaign, ‘Learn NPC, Read Between the Signs,’ to Drive Early Recognition and Treatment of Niemann-Pick Disease Type C New website launched in honor of Rare Disease Day, Feb. 28, 2025 Awareness campaign includes educational resources and testing information for individuals with suspected NPC. CELEBRATION, Fla., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies to people living with rare disease, today announced, on Rare Disease ...
Zevra Therapeutics Enters Agreement to Sell its Rare Pediatric Disease...
Zevra Therapeutics Enters Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million CELEBRATION, Fla., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that it has entered into a definitive asset purchase agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $150 million upon the closing of the transaction, which is expected to take place within 30 to 45 days...
Zevra to Report 2024 Fourth Quarter and Full Year Financial Results
Zevra to Report 2024 Fourth Quarter and Full Year Financial Results Company will host conference call on Tuesday, Mar. 11, 2025, at 4:30 p.m. ET CELEBRATION, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced it will report corporate and financial results for the fourth quarter and full year 2024 on Tuesday, Mar. 11, 2025. The Company will issue a news release after the market closes and host a conference call/audio webcas...
Zevra to Participate at Upcoming Investor Conferences
Zevra to Participate at Upcoming Investor Conferences CELEBRATION, Fla., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that members of Zevra’s executive leadership team will participate at the following March events: TD Cowen 45th Annual Health Care Conference on Wednesday, Mar. 5, 2025, at 10:30 a.m. ET.37th Annual ROTH Conference on Monday, Mar. 17, 2025, at 1:00 p.m. PT. Additionally, management will be available for one...
Paycom Software Inc: 1 director
A director at Paycom Software Inc sold 1,500 shares at 210.570USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Zevra Therapeutics to Present at the 21st Annual WORLDSymposium™
Zevra Therapeutics to Present at the 21st Annual WORLDSymposium™ Zevra to receive a 2025 New Treatment Award for MIPLYFFA™ at the 21st Annual WORLDSymposium Eight abstracts discussing data and clinical experience associated with MIPLYFFA accepted for poster presentation, with one poster selected for oral presentation by Dr. Eugen Mengel CELEBRATION, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare disease therapeutics company, today announced that eight abstracts discussing data and clinical ex...
Zevra Therapeutics to Participate at Upcoming Investor Conferences
Zevra Therapeutics to Participate at Upcoming Investor Conferences CELEBRATION, Fla., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage rare disease therapeutics company, today announced that members of Zevra’s executive leadership team will participate in the following February events. Guggenheim Securities SMID Cap Biotechnology Conference on Wednesday, Feb. 5, 2025, at 2:30 p.m. ET.Oppenheimer & Co. 35th Annual Healthcare Life Sciences Conference on Wednesday, Feb. 12, 2025, at 3:20 p.m. ET. Additionally, managemen...
- Jonathan Moreland
OXY OCCIDENTAL PETROLEUM CORPORATION
VRSN VERISIGN INC.
OMEX ODYSSEY MARINE EXPLORATION INC.
LNDC LANDEC CORP.
FPI FARMLAND PARTNERS REIT
DEA EASTERLY GOVERNMENT PROPERTIES INC
CDXS CODEXIS
ASA ASA
NEWT NEWTEK BUSINESS SERVICES INC.
ADC AGREE REALTY CORPORATION
CULP CULP INC.
FBK FB FINANCIAL CORPORATION
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
LW LAMB WESTON HOLDINGS INC.
ANAB ANAPTYSBIO INC.
DMLP DORCHESTER MINERALS L.P.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
ZIVO ZIVO BIOSCIENCE
LOVE INC.
FUND LOVESAC
ETON ROYCE FOCUS TRUST
MCFT INC.
PGNY ETON PHARMACEUTICALS
DCTH MASTERCRAFT BOAT HOLDINGS
ENX PROGYNY
REYN DELCATH SYSTEMS
PRLD EATON VANCE NEW YORK MUNICIPAL BOND FUND
NOTV REYNOLDS CONSUMER PRODUCTS INC.
PFX PRELUDE THERAPEUTICS
XLO INOTIV
NVCT INC.
ANEB PHENIXFIN CORP
BHVN XILIO THERAPEUTICS INC
ACXP NUVECTIS PHARMA INC
BUKS ANEBULO PHARMACEUTICALS INC
ECBK BIOHAVEN LTD
GLSI ACURX PHARMACEUTICALS INC
MEGI BUTLER NATIONAL CORP
SCWO ECB BANCORP INC.
CVI GREENWICH LIFESCIENCES INC
SRFM MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
OCX 374WATER INC
SIRI CVR ENERGY
TXO INC.
MRKR SURF AIR MOBILITY INC.
TTGT ONCOCYTE CORPORATION
DTIL SIRIUS XM HLDGS INC NEW
AMST MORNINGSTAR PARTNERS
WHLM L.P.
MARKER THERAPEUTICS INC
TECHTARGET INC.
PRECISION BIOSCIENCES INC.
AMESITE INC.
WILHELMINA INTERNATIONAL INC
- Jonathan Moreland
ASA ASA
PETS PETMED EXPRESS INC.
FBK FB FINANCIAL CORPORATION
JELD JELD-WEN HOLDING INC.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
BIGZ BLACKROCK INNOVATION AND GROWTH TST
CVI CVR ENERGY
MIO INC.
PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
- Jonathan Moreland
- Jonathan Moreland
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
ETON ETON PHARMACEUTICALS
RLAY RELAY THERAPEUTICS
BIGZ BLACKROCK INNOVATION AND GROWTH TST
BUKS BUTLER NATIONAL CORP
GLSI GREENWICH LIFESCIENCES INC
MEGI MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
MIO PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
EVM EATON VANCE INSD CALIF MUN BD FD
- Jonathan Moreland
OXY OCCIDENTAL PETROLEUM CORPORATION
HPP HUDSON PACIFIC PROPERTIES INC.
VVI VIAD CORP
VRSN VERISIGN INC.
OMEX ODYSSEY MARINE EXPLORATION INC.
MMS MAXIMUS INC.
KVHI KVH INDUSTRIES INC.
FPI FARMLAND PARTNERS REIT
FDX FEDEX CORPORATION
DEA EASTERLY GOVERNMENT PROPERTIES INC
CDXS CODEXIS
ASA ASA
NEWT NEWTEK BUSINESS SERVICES INC.
ADC AGREE REALTY CORPORATION
CULP CULP INC.
PLSE PULSE BIOSCIENCES
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
LW LAMB WESTON HOLDINGS INC.
ANAB ANAPTYSBIO INC.
DMLP DORCHESTER MINERALS L.P.
ZIVO ZIVO BIOSCIENCE
WHLM INC.
LOVE WILHELMINA INTERNATIONAL
FUND LOVESAC
MCFT ROYCE FOCUS TRUST
PGNY INC.
OXLC MASTERCRAFT BOAT HOLDINGS
ZYME PROGYNY
DCTH OXFORD LANE CAPITAL CORP.
REYN ZYMEWORKS INC.
PRLD DELCATH SYSTEMS
DLHC REYNOLDS CONSUMER PRODUCTS INC.
MASS PRELUDE THERAPEUTICS
NOTV DALEIGH HOLDINGS CORP
PFX 908 DEVICES
XLO INOTIV
NVCT INC.
ANEB PHENIXFIN CORP
BHVN XILIO THERAPEUTICS INC
BUKS NUVECTIS PHARMA INC
ECBK ANEBULO PHARMACEUTICALS INC
GLSI BIOHAVEN LTD
MEGI BUTLER NATIONAL CORP
SCWO ECB BANCORP INC.
SRFM GREENWICH LIFESCIENCES INC
OCX MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
SUNS 374WATER INC
SIRI SURF AIR MOBILITY INC.
TXO ONCOCYTE CORPORATION
MRKR SUNRISE REALTY TRUST
TTGT SIRIUS XM HLDGS INC NEW
KALA MORNINGSTAR PARTNERS
DTIL L.P.
MARKER THERAPEUTICS INC
TECHTARGET INC.
KALA BIO INC
PRECISION BIOSCIENCES INC.
- Jonathan Moreland
CDXS CODEXIS
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
ANAB ANAPTYSBIO INC.
FUND ROYCE FOCUS TRUST
GRX INC.
ZYME THE GABELLI HEALTHCARE & WELLNESSRX TRUST
BIGZ ZYMEWORKS INC.
GLSI BLACKROCK INNOVATION AND GROWTH TST
MEGI GREENWICH LIFESCIENCES INC
TXO MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
MORNINGSTAR PARTNERS
L.P.
- Jonathan Moreland
TTSH TILE SHOP HOLDINGS INC.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
ZIVO ZIVO BIOSCIENCE
ENX INC.
UAN EATON VANCE NEW YORK MUNICIPAL BOND FUND
BHVN CVR PARTNERS LP
BIGZ BIOHAVEN LTD
MIO BLACKROCK INNOVATION AND GROWTH TST
EVM PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
KALA EATON VANCE INSD CALIF MUN BD FD
KALA BIO INC
- Jonathan Moreland
TTSH TILE SHOP HOLDINGS INC.
PSEC PROSPECT CAPITAL CORPORATION
OMEX ODYSSEY MARINE EXPLORATION INC.
GLP GLOBAL PARTNERS LP
FDX FEDEX CORPORATION
DEA EASTERLY GOVERNMENT PROPERTIES INC
NEWT NEWTEK BUSINESS SERVICES INC.
ADC AGREE REALTY CORPORATION
AGR AVANGRID INC.
LW LAMB WESTON HOLDINGS INC.
DMLP DORCHESTER MINERALS L.P.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
LILA LIBERTY LATIN AMERICA A
LOVE LOVESAC
PGNY PROGYNY
ZYME ZYMEWORKS INC.
DCTH DELCATH SYSTEMS
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
ONEW ONEWATER MARINE
PRLD PRELUDE THERAPEUTICS
UAN CVR PARTNERS LP
NOTV INOTIV
RMBL INC.
VTYX RUMBLEON INC
QNRX VENTYX BIOSCIENCES INC
ANEB QUOIN PHARMACEUTICALS LTD
TCBX ANEBULO PHARMACEUTICALS INC
BIGZ THIRD COAST BANCSHARES INC
SKYH BLACKROCK INNOVATION AND GROWTH TST
SRFM SKY HARBOUR GROUP CORP
OCX SURF AIR MOBILITY INC.
MIO ONCOCYTE CORPORATION
SUNS PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
ASMB SUNRISE REALTY TRUST
BNTC ASSEMBLY BIOSCIENCES INC
EVM BENITEC BIOPHARMA INC
MRKR EATON VANCE INSD CALIF MUN BD FD
TTGT MARKER THERAPEUTICS INC
TECHTARGET INC.
- Jonathan Moreland
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
ZYME ZYMEWORKS INC.
DCTH DELCATH SYSTEMS
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
QNRX QUOIN PHARMACEUTICALS LTD
BIGZ BLACKROCK INNOVATION AND GROWTH TST
BUKS BUTLER NATIONAL CORP
SES SES AI CORPORATION
OCX ONCOCYTE CORPORATION
MIO PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
EVM EATON VANCE INSD CALIF MUN BD FD
- Jonathan Moreland
OXY OCCIDENTAL PETROLEUM CORPORATION
HPP HUDSON PACIFIC PROPERTIES INC.
VRSN VERISIGN INC.
TTSH TILE SHOP HOLDINGS INC.
RMAX RE/MAX HOLDINGS INC.
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
PBF PBF ENERGY INC. CLASS A
NMFC NEW MOUNTAIN FINANCE CORPORATION
MTDR MATADOR RESOURCES COMPANY
MMS MAXIMUS INC.
DLY LYONDELLBASELL INDUSTRIES NV
KVHI KVH INDUSTRIES INC.
HRZN HORIZON TECHNOLOGY FINANCE CORP.
GLP GLOBAL PARTNERS LP
FPI FARMLAND PARTNERS REIT
FISI FINANCIAL INSTITUTIONS INC.
FFIC FLUSHING FINANCIAL CORP.
CNC CENTENE CORPORATION
CULP CULP INC.
FI FRANK'S INTERNATIONAL NV
NSC NORFOLK SOUTHERN CORPORATION
PETS PETMED EXPRESS INC.
PLSE PULSE BIOSCIENCES
SENS SENSEONICS HOLDINGS
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
TDW TIDEWATER INC
DOW DOW INC.
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
BCYC BICYCLE THERAPEUTICS
OXLC OXFORD LANE CAPITAL CORP.
PHAT PHATHOM PHARMACEUTICALS
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
REYN REYNOLDS CONSUMER PRODUCTS INC.
PRLD PRELUDE THERAPEUTICS
DLHC DALEIGH HOLDINGS CORP
MASS 908 DEVICES
CTGO CONTANGO ORE INC.
UAN CVR PARTNERS LP
PFX PHENIXFIN CORP
RMBL RUMBLEON INC
XLO XILIO THERAPEUTICS INC
NVCT NUVECTIS PHARMA INC
BIGZ BLACKROCK INNOVATION AND GROWTH TST
BHRB BURKE & HERBERT BANK & TR/VA
ECBK ECB BANCORP INC.
DINO HF SINCLAIR CORP
TKO TKO GROUP HOLDINGS
GAM INC.
MIO GENERAL DE ALQUILER DE MAQUINARIA
SUNS PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
MDRR SUNRISE REALTY TRUST
SIRI MEDALIST DIVERSIFIED REIT INC.
EVM SIRIUS XM HLDGS INC NEW
TXO EATON VANCE INSD CALIF MUN BD FD
MORNINGSTAR PARTNERS
L.P.
- Jonathan Moreland
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.